Medindia

X

Low-dose Oral Interferon may Prevent Relapse of Hepatitis C Virus Infection

by Bidita Debnath on  March 11, 2014 at 11:13 PM Research News   - G J E 4
Chronic hepatitis C virus (HCV) infection can lead to serious diseases such as cancer of the liver and cirrhosis, so viral clearance and prevention of relapse are important treatment goals.
 Low-dose Oral Interferon may Prevent Relapse of Hepatitis C Virus Infection
Low-dose Oral Interferon may Prevent Relapse of Hepatitis C Virus Infection
Advertisement

Low-dose oral interferon may reduce the risk of HCV relapse in patients with mild liver fibrosis according to a study published in Journal of Interferon & Cytokine Research, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Interferon & Cytokine Research website.

Advertisement
In "A Double-Blind Randomized Controlled Study to Evaluate the Efficacy of Low-Dose Oral Interferon-Alpha in Preventing Hepatitis C Relapse," Chuan-Mo Lee and coauthors from several universities and hospitals in Taiwan present the results of a clinical trial comparing the effects of 24 weeks of treatment with two doses of oral interferon-alpha or placebo in patients who achieved viral clearance after successful HCV therapy.

"This is a highly significant study relevant to the optimal use of IFN for HCV treatment," says Co-Editor-in-Chief Ganes C. Sen, PhD, Chairman, Department of Molecular Genetics, Cleveland Clinic Foundation, Ohio.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All